Intercept Pharmaceuticals, Inc.


Updates from The Motley Fool

Latest updates on Intercept Pharmaceuticals from Fool.com.  The Fool has written over 100 articles on Intercept Pharmaceuticals.
5 Top Stocks for January

Start the year right by buying a piece of these five compelling businesses.



Stock Performance

View Interactive ICPT Charts
Sponsored by

Key Data Points

Primary metrics and data points about Intercept Pharmaceuticals.
Current Price: $111.65
Prev Close: $110.67
Open: $111.58
Bid: $111.65
Ask: $119.00
Day's Range: $109.82 - $113.00
52wk Range: $51.05 - $121.92
Volume: 437,994
Avg Vol 630,592
Market Cap: $3B
P/E (ttm): -8.47
EPS (ttm): ($13.06)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Intercept Pharmaceuticals.
CAPS Rating 4 out of 5
 
99 Outperform
32 Underperform
CAPS All Stars
 
32 Outperform
5 Underperform

How do you think Intercept Pharmaceuticals will perform against the market?



You pick for Intercept Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark Pruzanski, CEO

46% Approve

Based on 17 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Intercept Pharmaceuticals.

Intercept Pharmaceuticals, Inc.

  • Exchange: NASDAQ